• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Daiichi Sankyo discontinues development of Nafamostat in Japan

    BIOSPECTRUM ASIA

    Daiichi Sankyo begins phase 1 trial in Japan for nafamostat inhalation formu

    PHARMABIZ

    Chong Kun Dang proceeds to phase 2 trial in Russia to treat COVID-19

    KOREAN HERALD

    The University of Tokyo, RIKEN, Nichi-Iko & Daiichi Sankyo ink R&D on nafamostat

    PHARMABIZ

    Sun Pharma to trial Nafamostat for Covid-19 treatment

    CLINICALTRIALSARENA

    Covid-19: Sun Pharma gets DCGI nod for nafamostat clinical trial in patients

    LIVEMINT

    Korean researchers find drug that is more effective in treating COVID-19 than remdesivir

    PHARMAFILE

    Univ. of Tokyo Starts Testing Avigan Plus Futhan for COVID-19

    PHARMA JAPAN

    Ensysce, a California Based Biotech Company With a Mission to Solve the

    BIOSPACE

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.